Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

JAMA : the Journal of the American Medical Association
George L BakrisMineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group

Abstract

Steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with chronic kidney disease but may be underused because of a high risk of adverse events. To evaluate the safety and efficacy of different oral doses of the nonsteroidal mineralocorticoid receptor antagonist finerenone, given for 90 days to patients with diabetes and high or very high albuminuria who are receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker. Randomized, double-blind, placebo-controlled, parallel-group study conducted at 148 sites in 23 countries. Patients were recruited from June 2013 to February 2014 and the study was completed in August 2014. Of 1501 screened patients, 823 were randomized and 821 received study drug. Participants were randomly assigned to receive oral, once-daily finerenone (1.25 mg/d, n = 96; 2.5 mg/d, n = 92; 5 mg/d, n = 100; 7.5 mg/d, n = 97; 10 mg/d, n = 98; 15 mg/d, n = 125; and 25 mg/d, n = 119) or matching placebo (n = 94) for 90 days. The primary outcome was the ratio of the urinary albumin-creatinine ratio (UACR) at day 90 vs at baseline. Safety end points were changes from baseline in serum potassium and estimat...Continue Reading

Citations

Feb 6, 2016·Clinical and Experimental Nephrology·Shigeru Shibata
Jan 29, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Kouichi TamuraSatoshi Umemura
Dec 5, 2015·European Journal of Heart Failure·Peter BramlageRoland E Schmieder
Oct 16, 2015·Journal of Cardiovascular Pharmacology·Elise Gomez-Sanchez
Mar 2, 2016·American Journal of Hypertension·Wakako Kawarazaki, Toshiro Fujita
Dec 30, 2015·Chinese Medical Journal·Yan-Huan Feng, Ping Fu
Mar 5, 2016·Current Opinion in Pharmacology·Jun Yang, Morag J Young
Nov 18, 2015·Current Opinion in Nephrology and Hypertension·James M Luther
Oct 16, 2015·Nature Reviews. Nephrology·Matthew R Weir
Apr 5, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Martin H de Borst, Gerjan Navis
Apr 8, 2016·Nature Reviews. Cardiology·Gema Ruiz-HurtadoLuis M Ruilope
Sep 29, 2015·Lancet·Hillel Sternlicht, George L Bakris
Mar 10, 2016·Expert Opinion on Drug Safety·Bertram Pitt, Patrick Rossignol
Apr 15, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Naoki SatoUNKNOWN ARTS-HF Japan study group
May 3, 2016·Environmental Toxicology and Pharmacology·Junxian YuXinyu Liu
May 28, 2016·Nature Reviews. Drug Discovery·Matthew D Breyer, Katalin Susztak
May 4, 2016·Current Opinion in Nephrology and Hypertension·Duygu Batu Demir, Mark E Cooper
Jun 10, 2016·International Journal of Clinical Practice·O J ZiffD Goldsmith
Jun 9, 2016·Expert Opinion on Investigational Drugs·Maria Vanessa Perez-GomezBeatriz Fernandez-Fernandez
Aug 11, 2016·Metabolism: Clinical and Experimental·Pingping YangGaosi Xu
Jul 28, 2016·Pharmacology & Therapeutics·Achim Lother, Lutz Hein
Aug 16, 2016·Bioorganic & Medicinal Chemistry Letters·Jehrod BrennemanSteve Pullen
Aug 29, 2016·Journal of Nephrology·Vincenzo BellizziUNKNOWN “Conservative Treatment of CKD” Study Group of the Italian Society of Nephrology
Aug 3, 2016·The Journal of Pharmacology and Experimental Therapeutics·Steven M WeldonNicholas F Brown
Aug 24, 2016·Expert Opinion on Therapeutic Patents·Matthieu Collin, Frédéric Jaisser
Jan 18, 2016·The Lancet. Diabetes & Endocrinology·Martin GallagherVlado Perkovic
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association
Jul 9, 2016·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Anand SrivastavaRobert D Toto
Feb 10, 2017·Future Cardiology·Joseph J CuthbertAndrew L Clark
Jan 21, 2017·Journal of Diabetes Investigation·Li-Jing SunGeng-Ru Jiang
Oct 21, 2016·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shigeru ShibataShunya Uchida
May 12, 2017·The Korean Journal of Internal Medicine·Alain Gay, Peter Kolkhof
May 10, 2017·Expert Opinion on Pharmacotherapy·Pantelis A SarafidisLuis M Ruilope
May 26, 2017·Expert Opinion on Drug Discovery·Maria Tamargo, Juan Tamargo
Nov 30, 2016·Hemodialysis International·Tushar Chopra, Mitchell H Rosner
Jun 1, 2017·Clinical Pharmacology and Therapeutics·C-J ChengC-L Huang
Sep 1, 2017·Journal of Hypertension·Cristiana CatenaLeonardo A Sechi
Mar 14, 2018·American Journal of Hypertension·Ryo MorimotoFumitoshi Satoh
Dec 10, 2017·Diabetes Care·UNKNOWN American Diabetes Association

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.